Evaluation of disc diffusion and MIC testing for determining susceptibility of Pseudomonas aeruginosa isolates to topical enrofloxacin/silver sulfadiazine

Australian Veterinary Journal

Volumn 85, Issue 11, 2007, Pages 464-466

  Trott, D J ^a   Moss, S M ^a   See, A M ^a   Rees, R ^b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b Bayer Australia Ltd   (Australia)

Author keywords

Drug resistance; MIC testing; Microbial pathogens; Pseudomonas aeruginosa

Indexed keywords

ANTIINFECTIVE AGENT; ENROFLOXACIN; QUINOLONE DERIVATIVE; SULFADIAZINE SILVER;

ANIMAL; ANIMAL DISEASE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COUNT; DOG; DOG DISEASE; DOSE RESPONSE; DRUG COMBINATION; DRUG EFFECT; GRAM NEGATIVE INFECTION; MICROBIOLOGY; OTITIS MEDIA; PSEUDOMONAS AERUGINOSA; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ANIMALS; ANTI-BACTERIAL AGENTS; COLONY COUNT, MICROBIAL; DOG DISEASES; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, BACTERIAL; DRUG THERAPY, COMBINATION; FLUOROQUINOLONES; OTITIS MEDIA; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SILVER SULFADIAZINE;

PSEUDOMONAS AERUGINOSA;

EID: 35548935012     PISSN: 00050423     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1751-0813.2007.00223.x     Document Type: Article

References (7)

1. NCCLS. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals. Approved Standard M31-A2. 2nd edn. National Committee for Clinical Laboratory Standards, Wayne, PA, 2002.
2. Foster AP, DeBoer DJ. The role of Pseudomonas in canine ear disease. Compend Contin Educ Pract Vet 1998 20 : 909 918.
3. Poole K, Krebes K, McNally C, Neshat S. Multiple antibiotic resistance in Pseudomonas aeruginosa: evidence for involvement of an efflux operon. J Bacteriol 1993 175 : 7363 7372.
4. Hancock REW. Resistance mechanisms in Pseudomonas aeruginosa and other non-fermentative Gram-negative bacteria. Clin Infect Dis 1998 27 (Suppl 1 S93 99.
5. Anon. Freedom of Information summary Original New Animal Drug Application NADA 141-176 Baytril Otic. 2006. http://www.fda.gov/cvm/FOI/141-176.pdf. Accessed 14 February 2006.
6. NHMRC. EAGAR importance ratings and summary of antibiotic uses in humans in Australia. http://www.nhmrc.gov.au/about/committees/expert/eagar/index.htm. 2006. Accessed 16 April 2007.
7. Walker RD. The use of fluoroquinolones for companion animal antimicrobial therapy. Aust Vet J 2000 78 : 84 90.